|
|
|
|
| LEADER |
00000cam a22000008i 4500 |
| 001 |
12576282 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
180711s2018 dcu ob 001 0 eng |
| 005 |
20230310182510.3 |
| 010 |
|
|
|a 2018033236
|
| 019 |
|
|
|a 1099529317
|
| 020 |
|
|
|a 0841233292
|
| 020 |
|
|
|a 9780841233294
|q (electronic bk.)
|
| 020 |
|
|
|z 9780841233379
|q (alk. paper)
|
| 035 |
|
|
|a (OCoLC)1044776964
|z (OCoLC)1099529317
|
| 035 |
|
9 |
|a (OCLCCM-CC)1044776964
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d UIU
|d OCLCO
|d CASSC
|d OCLCO
|d OCLCF
|d AU@
|d OCLCO
|d OCLCA
|d YDX
|d OCLCQ
|d OCLCO
|d OCLCA
|d N$T
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a d------
|
| 049 |
|
|
|a MAIN
|
| 050 |
1 |
0 |
|a QR189
|
| 060 |
1 |
0 |
|a QW 805
|
| 084 |
|
|
|a MED044000
|2 bisacsh
|
| 130 |
0 |
|
|a Carbohydrate-based vaccines (Prasad)
|
| 245 |
1 |
0 |
|a Carbohydrate-based vaccines :
|b from concept to clinic /
|c A. Krishna Prasad, editor.
|
| 263 |
|
|
|a 1812
|
| 264 |
|
1 |
|a Washington DC :
|b American Chemical Society,
|c 2018.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a ACS symposium series ;
|v 1290
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Glycoconjugate vaccines : the clinical journey -- Immunological mechanisms of glycoconjugate vaccines -- Design and development of glycoconjugate vaccines -- Manufacturing considerations for glycoconjugate vaccines -- Multivalent meningococcal conjugate vaccines : chemical conjugation strategies used for the preparation of vaccines licensed or in clinical trials -- The role of molecular modeling in predicting carbohydrate antigen conformation and understanding vaccine immunogenicity -- Advances in synthetic approaches towards glycoantigens -- Formulation development of glycoconjugate vaccines for low and middle-income countries -- Pre-clinical assessment of glycoconjugate vaccines -- Campylobacter jejuni capsule polysaccharide conjugate vaccine -- Chemistry manufacturing, control and licensure for carbohydrate-based vaccines -- Lessons learned and future challenges in the design and manufacture of glycoconjugate vaccines.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher; resource not viewed.
|
| 650 |
|
0 |
|a Vaccines.
|0 http://id.loc.gov/authorities/subjects/sh85141718
|
| 650 |
|
0 |
|a Glycoconjugates.
|0 http://id.loc.gov/authorities/subjects/sh92001641
|
| 650 |
|
0 |
|a Carbohydrates
|x Immunology.
|
| 650 |
|
0 |
|a Carbohydrates
|x Therapeutic use.
|
| 650 |
|
0 |
|a Glycoconjugates
|x Therapeutic use.
|
| 650 |
|
0 |
|a Glycoconjugates
|x Immunology.
|
| 650 |
|
0 |
|a Glycoconjugates
|x Design and construction.
|
| 650 |
|
0 |
|a Carbohydrate drugs
|x Design and construction.
|
| 650 |
|
0 |
|a Meningococcal infections
|x Chemotherapy.
|
| 650 |
|
0 |
|a Bioconjugates
|x Immunology.
|
| 650 |
|
0 |
|a Antibody-drug conjugates.
|0 http://id.loc.gov/authorities/subjects/sh88000795
|
| 650 |
|
0 |
|a Clinical trials.
|0 http://id.loc.gov/authorities/subjects/sh85027069
|
| 650 |
|
0 |
|a Clinical medicine
|x Research.
|0 http://id.loc.gov/authorities/subjects/sh85083133
|
| 650 |
|
0 |
|a Antigens
|x Molecular aspects
|x Models.
|
| 650 |
|
0 |
|a Immunogenetics.
|0 http://id.loc.gov/authorities/subjects/sh85064560
|
| 650 |
|
0 |
|a Glycomics
|x Therapeutic use.
|
| 650 |
|
0 |
|a Glycoconjugates
|x Therapeutic use
|z Developing countries.
|
| 650 |
|
0 |
|a Polysaccharides
|x Immunology.
|
| 650 |
|
0 |
|a Carbohydrate drugs
|x Industrial applications.
|
| 650 |
|
0 |
|a Carbohydrate drugs
|x Licenses.
|
| 650 |
|
0 |
|a Glycoconjugates
|x Therapeutic use
|x Forecasting.
|
| 650 |
1 |
2 |
|a Vaccines.
|
| 650 |
1 |
2 |
|a Glycoconjugates.
|
| 650 |
2 |
2 |
|a Carbohydrates
|x immunology.
|
| 650 |
|
7 |
|a MEDICAL
|x Immunology.
|2 bisacsh
|
| 650 |
|
7 |
|a Antibody-drug conjugates.
|2 fast
|0 (OCoLC)fst00810453
|
| 650 |
|
7 |
|a Carbohydrates
|x Immunology.
|2 fast
|0 (OCoLC)fst00846759
|
| 650 |
|
7 |
|a Clinical medicine
|x Research.
|2 fast
|0 (OCoLC)fst00864379
|
| 650 |
|
7 |
|a Clinical trials.
|2 fast
|0 (OCoLC)fst00864429
|
| 650 |
|
7 |
|a Glycoconjugates.
|2 fast
|0 (OCoLC)fst00943768
|
| 650 |
|
7 |
|a Immunogenetics.
|2 fast
|0 (OCoLC)fst00967949
|
| 650 |
|
7 |
|a Vaccines.
|2 fast
|0 (OCoLC)fst01163573
|
| 651 |
|
7 |
|a Developing countries.
|2 fast
|0 (OCoLC)fst01242969
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Prasad, A. Krishna,
|e editor.
|
| 710 |
2 |
|
|a American Chemical Society,
|e issuing body.
|0 http://id.loc.gov/authorities/names/n78088941
|
| 710 |
2 |
|
|a American Chemical Society.
|b Division of Carbohydrate Chemistry,
|e sponsoring body.
|0 http://id.loc.gov/authorities/names/n78080940
|
| 710 |
2 |
|
|a American Chemical Society.
|b Cellulose and Renewable Materials Division,
|e sponsoring body.
|0 http://id.loc.gov/authorities/names/n2003005065
|
| 776 |
0 |
8 |
|i Print version:
|d Washington DC : American Chemical Society, 2018
|z 9780841233379
|w (DLC) 2018032978
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-2018-1290
|y American Chemical Society
|
| 856 |
4 |
0 |
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=2689914
|y eBooks on EBSCOhost
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|s b3404c60-d915-4152-84a7-1f2e54a76f5c
|i be9ffaf4-947d-5770-81ec-f7b634fb6029
|
| 928 |
|
|
|t Library of Congress classification
|a QR189
|l Online
|c UC-FullText
|u https://pubs.acs.org/doi/book/10.1021/bk-2018-1290
|z American Chemical Society
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=2689914
|z eBooks on EBSCOhost
|g ebooks
|i 12567650
|
